# Sight Sciences (SGHT) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/SGHT
## Company Profile
- Ticker: SGHT
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: MedTech, Ophthalmology
## Stock Data
- Close: 7.75 USD
- Market cap: 236139148.28 USD
- Last updated: 2026-08-11
## Business Overview
### Interventional Eye Care
Sight Sciences develops minimally invasive and noninvasive technologies intended to address underlying causes of glaucoma and dry-eye disease.
### Glaucoma Systems
OMNI and OMNI Edge are implant-free minimally invasive glaucoma-surgery systems that access Schlemm's canal and the trabecular meshwork. SION is a bladeless device used to excise trabecular meshwork.
### TearCare
TearCare applies localized heat to the eyelids so physicians can clear obstructed meibomian glands, addressing a major cause of evaporative dry-eye disease.
## Why The Stock Is Moving

As of Aug 11, 2026, SGHT closed up 0.65% at $7.75. No new same-company headline was identified in the current news window.

## Recent News
- 2026-08-05 20:05 EST — [Sight Sciences Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/SGHT/sight-sciences-reports-second-quarter-2026-financial-results-6e097262) — Source: Sight Sciences
- 2026-08-05 20:04 EST — [Sight Sciences Announces Aetna Coverage for OMNI and SION Surgical Systems](https://biopharmsignal.com/news/SGHT/sight-sciences-announces-aetna-coverage-for-omni-and-sion-surgical-systems-52d81027) — Source: Sight Sciences
- 2026-08-04 21:38 EST — [Sight Sciences Receives FDA 510(k) Clearance of the OMNI Ultra Surgical System](https://biopharmsignal.com/news/SGHT/sight-sciences-receives-fda-510-k-clearance-of-the-omni-ultra-surgical-system-8bb2f7b4) — Source: Sight Sciences
- 2026-07-22 20:05 EST — [Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/SGHT/sight-sciences-to-report-second-quarter-2026-financial-results-on-august-5-2026-ec2572f5) — Source: Sight Sciences
- 2026-05-06 20:05 EST — [Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance](https://biopharmsignal.com/news/SGHT/sight-sciences-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance) — Source: Sight Sciences